Internal link ProQR to Present its Ophthalmology Pipeline at ARVO, Highlighting Programs in Leber’s Congenital Amaurosis Type 10 (LCA 10) and Usher Syndrome mai 01, 2017 at 11:00 AM UTC
Internal link ProQR Announces Clearance of IND Application to Start Clinical Trial for QR-110 in Leber’s Congenital Amaurosis Type 10 Patients avril 27, 2017 at 11:00 AM UTC
Internal link ProQR to Present at the Deutsche Bank Health Care Conference avril 20, 2017 at 11:00 AM UTC
Internal link ProQR Announces the Grant of two Key Patents, protecting QR-010 for Cystic Fibrosis in the US and EU avril 03, 2017 at 11:00 AM UTC
Internal link ProQR Appoints David M. Rodman, MD as Chief Development Strategy Officer mars 27, 2017 at 11:00 AM UTC
Internal link ProQR to Present at Two Upcoming Investor Conferences in March mars 01, 2017 at 12:00 PM UTC
Internal link ProQR Announces Results for the Fourth Quarter and Full Year 2016 and Provides a Business Update février 28, 2017 at 12:00 PM UTC
Internal link On a Shared Quest to Find Treatments for Rare Diseases, ProQR Supports Rare Disease Day février 27, 2017 at 12:00 PM UTC
Internal link ProQR to Present at the LEERINK Partners Global Healthcare Conference février 07, 2017 at 12:00 PM UTC